SUBSCRIBE
SUBSCRIBE

Australia

New Pill Holds Promise for Fewer Side Effects in Treating Leukemia, Nature Medicine Reveals
January 7, 2013
 · 
1 min read
University of Sydney Researchers Identify an Early Predictor for Glaucoma
January 2, 2013
 · 
1 min read
Manipulating Transcription Factor Can Change Subtype of Breast Cancer, Garvan Institute of Medical Research Study
January 2, 2013
 · 
1 min read
Caffeine, Not Coffee, Aids in Weight Loss, University of Southern Queensland Study
December 28, 2012
 · 
1 min read
The Factor That Could Determine Future Breast Cancer Treatment, Garvan Institute of Medical Research Study
December 28, 2012
 · 
1 min read
Brain Scans Might Help Spot Risk for Bipolar Disorder, University of New South Wales Study
December 27, 2012
 · 
1 min read
Cancer Study Overturns Current Thinking About Gene Activation, Garvan Institute of Medical Research Reveals
December 19, 2012
 · 
1 min read
Radio Waves to Kidneys Lower Persistent High Blood Pressure, Baker IDI Heart and Diabetes Institute Study
December 18, 2012
 · 
1 min read
Beet Juice Lowers Blood Pressure, Baker IDI Heart and Diabetes Institute Study
December 18, 2012
 · 
1 min read
To Heal Chronic Wounds, Level Inflammation, University of Queensland Study
December 17, 2012
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
Australian Breast Cancer Innovators Close $27M Private Funding Round
February 12, 2026
 · 
5 min read
Press Releases
ImmuneSensor Therapeutics Doses First Patient with Aicardi Goutières Syndrome (AGS) in Phase 1b Clinical Study of cGAS inhibitor, IMSB301
February 12, 2026
 · 
5 min read
Press Releases
Amplia Therapeutics Announces Opening of US Sites for Amplicity Pancreatic Cancer Trial
February 11, 2026
 · 
4 min read
Press Releases
Genprex Announces IP Australia’s Intent to Grant Patent for Reqorsa® Gene Therapy in Combination with PD-L1 Antibodies to Treat Cancers
February 10, 2026
 · 
8 min read
Press Releases
Immutep Achieves 50% Enrolment in Global TACTI-004 (KEYNOTE-F91) Phase III Trial in 1L NSCLC
February 8, 2026
 · 
4 min read
Press Releases
Propanc Biopharma Unveils PRP: A Game-Changing Proenzyme Therapy Poised to Challenge Standard Cancer Treatments in the $3+ Billion Pancreatic Cancer Market
February 5, 2026
 · 
5 min read
Press Releases
Providence Therapeutics Announces Appointment of Leah Goodman to the Board of Directors
February 5, 2026
 · 
2 min read
Press Releases
Telix Full Year Results 2025 Investor Webcast Notification
February 4, 2026
 · 
5 min read
Press Releases
Medical-imaging company Imagion Biosystems Lodges IND with FDA for Phase 2 Trial of MagSense® HER2 targeted imaging agent
February 4, 2026
 · 
2 min read
Press Releases
Actinogen receives positive Interim Analysis recommendation from its independent Data Monitoring Committee to continue the XanaMIA pivotal Alzheimer’s disease trial
February 2, 2026
 · 
6 min read
Press Releases
AdvanCell Announces Collaboration and Exclusive Licensing Agreement with 48Hour Discovery to Develop a Novel Peptide-Based Lead-212 Radiotherapeutic for a Gastrointestinal Cancer with Significant Medical Need
February 2, 2026
 · 
3 min read
Press Releases
Alvotech enters supply and commercialization agreements for Canada and Australia & New Zealand covering multiple biosimilar candidates
February 2, 2026
 · 
4 min read
Press Releases
Amplia Therapeutics - Quarterly Activities and Cash Flow Reports - December 2025
February 1, 2026
 · 
7 min read
Press Releases
Kazia Therapeutics Announces Compelling Preclinical and Translational Data for Nuclear PD-L1 Degrader (NDL2)
February 1, 2026
 · 
11 min read
Press Releases
Alterity Therapeutics: Appendix 4C – Q2 FY26 Quarterly Cash Flow Report & Corporate Update
February 1, 2026
 · 
12 min read
Press Releases
SK bioscience Initiates International Phase 1/2 Clinical Trial of Universal Vaccine Candidate Targeting Sarbecovirus Family
January 29, 2026
 · 
5 min read
Press Releases
Immutep Quarterly Activities Report Q2 FY26
January 29, 2026
 · 
16 min read
Press Releases
ENA Respiratory Announces Dosing of First Participants in Phase II Study of INNA-051 Nasal Spray Designed to Protect Against Symptomatic Viral Respiratory Infections
January 29, 2026
 · 
4 min read
Press Releases
Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides a Corporate Update
January 29, 2026
 · 
18 min read
Press Releases
Radiopharm Theranostics Reports Half-Year Financial Results and Business Updates
January 28, 2026
 · 
8 min read
Load More